Find a Clinical Trial | Pfizer Clinical Trials

Join PfizerLink — a clinical research registry

Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

Sickle Cell Disease clinical trial

The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

Get started

Join a COVID-flu vaccine clinical trial near you

We’re working closely with doctors and scientists to conduct a clinical trial of combined COVID-19 and flu vaccines. See if you qualify.

Learn more

194 trials found

Recruiting

A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Neoplasms, Mesothelioma

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Urothelial Carcinoma

A Safety Study of SGN-35T in Adults With Advanced Cancers

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Urothelial Carcinoma

A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors

Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

Breast Cancer

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis